Your search history is turned on.
Date: April 23, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
OPTI PR (April 23, 2024) re Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research VANCOUVER, BC April 23, 2024 Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leadin...
Date: April 15, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
OPTI PR (April 15, 2024) re Optimi Health Achieves Mileston Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API) Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API) Three batches tested and validated by third-party laboratory VANCOUVER, BC April 15, 2024 Optimi He...
Date: April 9, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
OPTI PR (April 9, 2024) re Psilocybin Supply Agreement With New Zealand-Based Mtai Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mtai Medical Research Institute VANCOUVER, BC April 9, 2024 Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer...
Date: April 2, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
OPTI PR (April 2, 2024) re Finished Product Test Results and Certificate Of Analyses for GMP Natural Psilocybin Extract Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract Company has also completed the in-house encapsulation of 5mg & 10mg psilocybin extract dosage formats VANCOUVE...
Date: March 28, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
OPTI PR (March 28, 2024) re Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference Optimi CEO Bill Ciprick to speak on the future of GMP psychedelic manufacturing VANCOUVER, BC March 28, 2024 ...
Date: March 26, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
OPTI PR (March 26, 2024) re Supply MDMA for Psychedelic Research at Tel Aviv University Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University Supply agreement marks Optimis first international shipment of research-grade active pharmaceutical ingredient (API) MDMA to Israel VANCOUVER, BC March 26, 2024 Optimi Health Corp. ...
Date: February 29, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
OPTI post-IFRS 52-109FV2 [CFO] 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Jacob Safarik, Chief Financial Officer of Optimi Health Corp. certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Optimi Health Corp. (the issuer) fo...
OPTI post-IFRS 52-109FV2 [CEO] 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Bill Ciprick, Chief Executive Officer of Optimi Health Corp. certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Optimi Health Corp. (the issuer) for...
Optimi Health Corp - MDA - 2023-12-31(final) OPTIMI HEALTH CORP. MANAGEMENTS DISCUSSION AND ANALYSIS Overview This managements discussion and analysis (MD&A) is in respect of the operations and financial condition of Optimi Health Corp. (Optimi or the Company) and is dated as of February 29, 2024 and describes the operating and fina...
Optimi Health - 2023-12-31(final) Optimi Health Corp. Condensed interim consolidated financial statements Period Ended December 31, 2023 (Expressed in Canadian Dollars) Unaudited 1 Optimi Health Corp. Condensed Interim Consolidated Statements of Financial Position (Expressed ...